期刊文献+

沙丁胺醇口腔崩解片人体生物等效性研究 被引量:1

Bioequivalence of salbutamol orally disintegrating tablet in healthy subjects
下载PDF
导出
摘要 目的:比较沙丁胺醇口腔崩解片和普通片的人体生物利用度。方法:18名健康志愿受试者随机交叉单剂口服沙丁胺醇口腔崩解片和普通片,用高效液相色谱法测定血药浓度,3P97计算药动学参数和生物利用度。结果:口腔崩解片和普通片体内药时曲线符合二室模型,口腔崩解片和普通片Cmax分别为17.4 8±5 .5 2、16 .6 0±6 .2 1ng/ml,Tmax分别为2 .4 7±1.0 4和2 .0 3±1.17h ,AUC(0 -2 4) 分别为12 7.34±32 .6 6和131.4 2±37.73ng·h/ml,相对生物利用度为98.76 %±12 .92 %。结论:经方差分析和双单侧t检验。 Objective:To study the relative bioavailability and pharmacokinetics of salbutamol orally disintegrating tablet in 18 healthy male volunteers.Methods:A single dose of 8 mg of salbutamol orally disintegrating tablet was administered in a randomized crossover way in 18 volunteers and the plasma concentrations of salbutamol were determined by HPLC.The pharmacokinetic parameters were calculated with 3P97 pharmacokinetic program and the bioavailability was evaluated.Results:The concentration-time curve of two preparations fitted two compartment model.The peak plasma levels(cmax) of salbutamol orally disintegrating tablet and market of salbutamol were 17.48±5.52 and 16.60±6.21 ng/ml,respectively.The peak time(Tmax) were 2.47±1.04 and 2.03±1.17h and AUC(0-24) were 127.34±32.66 and 131.42±37.73 ng·h/ml,respectively,The relative bioavailability of salbutamol orally disintegrating tablet was 98.76%±12.92%.Conclusion:The results of two one-side tests suggest that salbutamol orally disintegrating tablet is bioequivalent to the market tablet of salbutamol.
出处 《重庆医科大学学报》 CAS CSCD 2005年第2期289-291,共3页 Journal of Chongqing Medical University
关键词 沙丁胺醇口腔崩解片 药动学 生物等效性 Salbutamol orally disintegrating tablet Pharmacokinetics Bioequivalence
  • 相关文献

参考文献5

二级参考文献22

  • 1[1]Evans ME, Paterson JW, Richards AJ, et al. Pharmacokinetics of inhaled salbutamol in asthmatic patients [J]. Br J Pharmacol, 1971,43(2):466-467.
  • 2[2]Walker SR, Evans ME, Richards AJ, et al. The clinical pharmacology of oral and inhaled salbutamol [J]. Clin Pharmacol Ther, 1972,13(6):861-867.
  • 3[3]Newnham DM, McDevitt DG, Lipworth BJ. Comparison of the extrapulmonary β2-adrenoceptor responses and pharmacokinetics of salbutamol given by standard metered dose inhalers and modified actuator device [J]. Br J Clin Pharmacol, 1993,36(5):445-450.
  • 4[4]Gupta RN, Fuller HD, Dolovich MB. Optimization of a column liquid chromatographic procedure for the determination of plasma salbutamol concentration [J]. J Chromatogr B, 1994,654(2):205-211.
  • 5[5]Emm T, Lesko LJ, Leslie J. Determination of albuterol in human serum by reversed-phase high-performance liquid chromatography with electrochemical detection [J]. J Chromatogr, 1988,427(1):188-194.
  • 6[6]Wong BJO, Hargeave FE. Bioequivalence of metered-dose inhaled medications [J]. J Allergy Clin Immunol, 1993,92(3):373-379.
  • 7[7]Chrystyn H. Standards for bioequivalence of inhaled products [J]. Clin Pharmacokinet, 1994,26(1):1-6.
  • 8[8]Lipworth BJ. Pharmacokinetics of inhaled drugs [J]. Br J Clin Pharmacol, 1996,42(6):697-705.
  • 9[9]Morgan DJ, Paull JD, Richmond BH. Pharmacokinetics of intravenous and oral salbutamol and its sulphate conjugate [J]. Br J Clin Pharmacol, 1986,22(5):587-593.
  • 10[10]Clark DJ, Smith JG, Clark G, et al. Lung bioavailability of generic and innovator formulations of inhaled salbutamol [J]. Eur Respir J, 1995,8(Suppl 19):259s-259s.

共引文献35

同被引文献35

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部